Electrophysiological correlates of amnestic mild cognitive impairment in a simon task

Jesús Cespón1, Santiago Galdo-Álvarez, Fernando Díaz

  • 1Department of Clinical Psychology and Biological Psychology, University of Santiago de Compostela, Santiago de Compostela, Galiza, Spain.

Plos One
|December 17, 2013
PubMed

Insights

Event-related potentials (ERPs) can identify early biomarkers for amnestic mild cognitive impairment (aMCI). Reduced N2pc amplitude indicates attentional decline in multiple-domain aMCI, while reduced LRP amplitude signals motor resource deficits in both single- and multiple-domain aMCI.

Area of Science:

  • Neuroscience
  • Cognitive Psychology
  • Biomarkers

Background:

  • Amnestic mild cognitive impairment (aMCI) is a precursor to Alzheimer's disease (AD).
  • Identifying early biomarkers for single-domain (sdaMCI) and multiple-domain (mdaMCI) subtypes is crucial for timely intervention.
  • Event-related potentials (ERPs) offer a non-invasive method to assess cognitive processes and detect subtle impairments.

Purpose of the Study:

  • To investigate the utility of ERPs, specifically the N2pc and LRP components, as biomarkers for sdaMCI and mdaMCI.
  • To assess differences in ERPs between healthy controls and individuals with amnestic MCI during a Simon task.
  • To determine the diagnostic accuracy of N2pc and LRP amplitudes for classifying MCI subtypes.

Main Methods:

  • EEG activity was recorded from 25 healthy participants and 30 aMCI patients (17 sdaMCI, 13 mdaMCI) performing a Simon task.
  • Analysis focused on the N2pc (visuospatial attention) and LRP (motor response) ERP components.
  • Sensitivity and specificity of N2pc and LRP amplitudes were calculated to evaluate their biomarker potential.

Main Results:

  • Reduced N2pc amplitude in mdaMCI patients compared to controls, indicating impaired attentional resource allocation.
  • N2pc amplitude showed moderate biomarker potential for mdaMCI (0.77 sensitivity, 0.76 specificity).
  • Reduced LRP amplitude in both sdaMCI and mdaMCI patients compared to controls, suggesting diminished motor resource availability.
  • LRP amplitude demonstrated strong biomarker potential for both aMCI subtypes (0.80 sensitivity, 0.92 specificity).

Conclusions:

  • ERP components, particularly LRP, show promise as sensitive and specific biomarkers for amnestic mild cognitive impairment subtypes.
  • N2pc and LRP amplitudes can help differentiate between healthy individuals and those with MCI, aiding in early diagnosis.
  • These findings support the use of ERPs in clinical settings for the early detection and characterization of aMCI.

Related Concept Videos